Sun Pharma gets regulatory approval for generic semaglutide in India
Sun Pharma will sell its generic semaglutide injection as Noveltreat, after the expiry of semaglutide patent in India
Sun Pharma will sell its generic semaglutide injection as Noveltreat, after the expiry of semaglutide patent in India
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
